You are here

A Study to Evaluate the Efficacy and Safety of Quinapril or Quinapril Plus Hydrochlorothiazide in Patients With Mild to Moderate Hypertension

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Cerrahpasa, Istanbul, 34300 Turkey
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Hypertension
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
19-65 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- A clinical diagnosis of mild to moderate primary hypertension ("Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure,
6th report" Stage I or II)

- Sitting diastolic blood pressure between 90 mmHg and 109 mmHg and systolic blood
pressure between 140 mmHg and 179 mmHg at the end of the no-treatment run-in period

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects with secondary hypertension

- Subjects with serious cardiac disease (including myocardial infarction in the last 3
months or decompensated heart failure)

- Subjects who do not accept to stop using any other antihypertensive treatment during
the run-in period and the treatment period of the study

NCT00651287
Pfizer
Completed
A Study to Evaluate the Efficacy and Safety of Quinapril or Quinapril Plus Hydrochlorothiazide in Patients With Mild to Moderate Hypertension

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now